Literature DB >> 6292584

5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia.

T A Sylwestrowicz, D D Ma, P P Murphy, M Massaia, H G Prentice, A V Hoffbrand, M F Greaves.   

Abstract

Three enzymes concerned in purine degradation, 5'nucleotidase (5'NT), adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) have been measured biochemically in the bone marrow or peripheral blood blasts from 75 patients with acute leukaemia, from 18 patients with blast crisis of chronic granulocytic leukaemia and in the bone marrow and peripheral blood lymphocytes from 14 normal donors. Characteristic patterns among the different sub-types of acute leukaemia have been detected, with high ADA, low 5'NT and PNP in Thy-ALL, high 5'NT and ADA in c-ALL, high PNP and low ADA in AML. The cells in CGL blast transformation resembled the enzymatic pattern of either AML or c-ALL respectively. However, no significant correlation was found between any pair of enzymes in any group of leukaemia, normal bone marrow or peripheral blood lymphocytes studied here.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292584     DOI: 10.1016/0145-2126(82)90004-2

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  PORPHOBILINOGEN DEAMINASE AND ADENOSINE DEAMINASE ACTIVITY AS A POSSIBLE DIAGNOSTIC AID IN LYMPHATIC LEUKEMIAS.

Authors:  Alka N Sontakke; Y V Sharma
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Multiple myeloma: ecto-5' nucleotidase deficiency of suppressor/cytotoxic (CD8) lymphocytes is a marker for the expansion of suppressor T cells.

Authors:  M Massaia; U Dianzani; P Pioppo; E Sibilla; M Boccadoro; A Pileri
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

3.  Surface expression of adenosine deaminase in mitogen-stimulated lymphocytes.

Authors:  M Martin; J J Centelles; J Huguet; F Echevarne; D Colomer; J L Vives-Corrons; R Franco
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

Review 4.  Biochemical enzyme analysis in acute leukaemia.

Authors:  H G Drexler; G Gaedicke; J Minowada
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

Review 5.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

6.  Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome.

Authors:  M J Cowan; R O Brady; K J Widder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

Review 7.  Enzymes of purine metabolism in lymphoid neoplasms, clinical relevance for treatment with enzyme inhibitors.

Authors:  A D Ho; K Ganeshaguru
Journal:  Klin Wochenschr       Date:  1988-06-01

Review 8.  Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Biochemical and immunological differentiation of human thymocytes induced by thymic hormones.

Authors:  A D Ho; D D Ma; G Price; W Hunstein; A V Hoffbrand
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.